2026 data FDA MAUDE openFDA FDA Class II

Implantable Transprostatic Tissue Retractor System

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA Class II (moderate risk, special controls required), regulated under 21 CFR §876.5530 (Gastroenterology, Urology panel).

FDA MAUDE casebook

openFDA event book Implantable Transprostatic Tissue Retractor… LIGHT-BOOK · MAUDE

#915 of 1000 · 471 reports · 2013–2026

  • BOOK 471 reports
  • RANK #915 of 1000
  • DEATH 12 death-typed
  • INJ 231 injury-typed
  • MALF 228 malfunction
  • SPAN 2013–2026
  • PEAK 2025: 69
  • PHOTO Mask, Oxygen

Nearest event-volume peer: Mask, Oxygen (1 report gap)

Implantable Transprostatic Tissue Retractor System sits #915 of 1000 among tracked device types with 471 MAUDE reports spanning 2013–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Similar-volume device →

Injury-coded reports run above the device-type norm

Implantable Transprostatic Tissue Retractor… carries 49.0% INJURY-coded reports, 18.8pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.

  • DEATH 2.5% corpus 1.5% · above corpus mean (+1.0 pp)
  • INJ 49.0% corpus 30.3% · above corpus mean (+18.8 pp)
  • MALF 48.4% corpus 64.8% · below corpus mean (-16.4 pp)

Lead product-problem code Adverse Event Without Identified Device or Use Problem is 50% of coded problems · Top event location is 59% of location-tagged rows .

Implantable Transprostatic Tissue Retractor… in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Implantable Transprostatic Tissue Retractor System carries 471 MAUDE reports, ranked #915 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Injury 231 (49.0%)
Malfunction 228 (48.4%)
Death 12 (2.5%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

239 (42.2%)
Required Intervention 111 (19.6%)
Hospitalization 81 (14.3%)
R 60 (10.6%)
Other 21 (3.7%)
H 18 (3.2%)
Death 11 (1.9%)
O 10 (1.8%)
L 6 (1.1%)
Life Threatening 4 (0.7%)
S 2 (0.4%)
Disability 2 (0.4%)
D 1 (0.2%)

Top Product Problems

Adverse Event Without Identified Device or Use Problem 219
Fracture 91
Break 21
Misfire 20
Appropriate Device Problem Term/Code Not Available 13
Detachment of Device or Device Component 8
Device Handling Problem 8
Failure to Fire 8
Insufficient Device Problem Information 7
Material Integrity Problem 7
Use of Device Problem 7
Firing Problem 5
Manufacturing, Packaging or Shipping Problem 5
Patient-Device Incompatibility 5
Retraction Problem 4
Device Dislodged or Dislocated 3
Improper or Incorrect Procedure or Method 3
Material Twisted/Bent 3
Therapeutic or Diagnostic Output Failure 3
Defective Device 2

Yearly Trend

13
2013: 1
15
2015: 6
16
2016: 8
17
2017: 8
18
2018: 17
19
2019: 47
20
2020: 65
21
2021: 50
22
2022: 55
23
2023: 52
24
2024: 37
25
2025: 69
26
2026: 56

Reports rose to 69 in 2025, up from an average of 45 in the two years before - a recent-year increase, not a lifetime pattern.

Related Entities for Implantable Transprostatic Tissue Retractor System

Event Locations

277 (58.8%)
I 150 (31.8%)
NO INFORMATION 24 (5.1%)
HOSPITAL 17 (3.6%)
AMBULATORY SURGICAL FACILITY 3 (0.6%)

Nationwide devices with a comparable volume-and-death footprint

Two openFDA-derived peer sets for Implantable Transprostatic Tissue Retractor…: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (471 here).

Similar death-typed counts

Nearest other device types by death-typed report count (12 here), distinct from the volume row.

Disclaimer: MAUDE figures for Implantable Transprostatic Tissue Retractor… are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Implantable Transprostatic Tissue Retractor…; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.